In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Hookipa Pharma Inc (NASDAQ: HOOK) closed at $1.86 in the last session, down -1.59% from day before closing price of $1.89. In other words, the price has decreased by -$1.59 from its previous closing price. On the day, 97177.0 shares were traded. HOOK stock price reached its highest trading level at $1.96 during the session, while it also had its lowest trading level at $1.85.
Ratios:
We take a closer look at HOOK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 3.26. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on December 20, 2024, Downgraded its rating to Sector Perform and sets its target price to $2 from $48 previously.
On November 15, 2024, RBC Capital Mkts reiterated its Outperform rating and also upped its target price recommendation from $50 to $48.
BofA Securities Downgraded its Buy to Underperform on December 02, 2022, while the target price for the stock was maintained at $0.50.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOOK now has a Market Capitalization of 22421370 and an Enterprise Value of -36088384. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.37 while its Price-to-Book (P/B) ratio in mrq is 0.31. Its current Enterprise Value per Revenue stands at -0.692 whereas that against EBITDA is 0.756.
Stock Price History:
Over the past 52 weeks, HOOK has reached a high of $105.00, while it has fallen to a 52-week low of $1.75. The 50-Day Moving Average of the stock is -29.93%, while the 200-Day Moving Average is calculated to be -93.93%.
Shares Statistics:
According to the various share statistics, HOOK traded on average about 70.68K shares per day over the past 3-months and 143700 shares per day over the past 10 days. A total of 9.66M shares are outstanding, with a floating share count of 7.19M. Insiders hold about 40.31% of the company’s shares, while institutions hold 25.08% stake in the company. Shares short for HOOK as of 1730332800 were 36244 with a Short Ratio of 0.43, compared to 1727654400 on 35190. Therefore, it implies a Short% of Shares Outstanding of 36244 and a Short% of Float of 0.47000000000000003.
Earnings Estimates
The dynamic stock of Hookipa Pharma Inc (HOOK) is currently attracting attention from 1.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$2.44 and -$2.44 for the fiscal current year, implying an average EPS of -$2.44. EPS for the following year is -$1.9, with 1.0 analysts recommending between -$1.9 and -$1.9.
Revenue Estimates
According to 2 analysts, the current quarter’s revenue is expected to be $6.25M. It ranges from a high estimate of $10.5M to a low estimate of $2M. As of the current estimate, Hookipa Pharma Inc’s year-ago sales were $7.41M
A total of 2 analysts have provided revenue estimates for HOOK’s current fiscal year. The highest revenue estimate was $53.09M, while the lowest revenue estimate was $44.6M, resulting in an average revenue estimate of $48.85M. In the same quarter a year ago, actual revenue was $20.13MBased on 2 analysts’ estimates, the company’s revenue will be $19.25M in the next fiscal year. The high estimate is $25M and the low estimate is $13.5M.
